Recombigen Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 09-12-2024
- Paid Up Capital ₹ 5.11 M
as on 09-12-2024
- Company Age 25 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.74 Cr
as on 09-12-2024
- Satisfied Charges ₹ 1.10 Cr
as on 09-12-2024
- Revenue 11.94%
(FY 2023)
- Profit 7.26%
(FY 2023)
- Ebitda 15.81%
(FY 2023)
- Net Worth 33.01%
(FY 2023)
- Total Assets 22.64%
(FY 2023)
About Recombigen Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 5.11 M.
The company currently has active open charges totaling ₹8.74 Cr. The company has closed loans amounting to ₹1.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Radhika Beri, Rajesh Beri, and Rishu Beri serve as directors at the Company.
- CIN/LLPIN
U24231DL1999PTC097838
- Company No.
097838
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jan 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Recombigen Laboratories Private Limited offer?
Recombigen Laboratories Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Silica Gel, Face Mask & Medical PPE Kits, Face Mask, Chemical Reagents & Catalysts, Laboratory Reagents, White Silica Gel, Rapid Test Kit, Cholesterol Test Kit, Laboratory Plasticware.
Who are the key members and board of directors at Recombigen Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Beri  | Director | 07-Jan-1999 | Current |
| Radhika Beri | Director | 20-Apr-2022 | Current |
| Rishu Beri | Director | 19-Mar-2019 | Current |
Financial Performance of Recombigen Laboratories.
Recombigen Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.94% increase. The company also saw a slight improvement in profitability, with a 7.26% increase in profit. The company's net worth Soared by an impressive increase of 33.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Recombigen Laboratories?
Unlock access to Recombigen Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 08 Aug 2022 | ₹8.10 M | Open |
Others Creation Date: 30 Jan 2021 | ₹1.75 M | Open |
Axis Bank Limited Creation Date: 21 Jun 2019 | ₹1.92 M | Open |
How Many Employees Work at Recombigen Laboratories?
Recombigen Laboratories has a workforce of 7 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Recombigen Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Recombigen Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
